DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $204,113 | -31.0% | 9,894 | -1.4% | 0.00% | – |
| Q2 2023 | $296,015 | +12.6% | 10,031 | -12.1% | 0.00% | – |
| Q1 2023 | $262,817 | -4.7% | 11,407 | +15.0% | 0.00% | – |
| Q4 2022 | $275,792 | +25.4% | 9,917 | +101.3% | 0.00% | – |
| Q4 2021 | $220,000 | -29.3% | 4,926 | -20.2% | 0.00% | – |
| Q3 2021 | $311,000 | -37.9% | 6,171 | -3.4% | 0.00% | – |
| Q2 2021 | $501,000 | +17.3% | 6,389 | -14.6% | 0.00% | – |
| Q1 2021 | $427,000 | -32.3% | 7,485 | -0.6% | 0.00% | -100.0% |
| Q4 2020 | $631,000 | – | 7,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
| Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
| Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
| Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
| MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
| Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
| PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
| HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |